Kimberly-Clark to Acquire Tylenol Maker Kenvue
Kimberly-Clark announced a cash and stock acquisition of Kenvue, valued at approximately $48.7 billion.
The Merger
Upon completion, Kimberly-Clark shareholders will own about 54% of the combined company, while Kenvue shareholders will hold 46%.
Key Brands
- Kenvue’s Tylenol, Listerine, and Band-Aid
- Kimberly-Clark’s Cottonelle, Huggies, and Kleenex
“We will serve billions of consumers across every stage of life.” - Mike Hsu, Kimberly-Clark Chairman and CEO
Leadership
Mike Hsu will lead as chairman and CEO of the merged company, with three Kenvue board members joining Kimberly-Clark’s board upon closing.
Author’s summary: Kimberly-Clark acquires Kenvue for $48.7 billion.